Androstanolone benzoate
Appearance
(Redirected from Ermalone Amp)
Clinical data | |
---|---|
Trade names | Ermalone-Amp, Hermalone, Sarcosan |
Other names | Stanolone benzoate; Dihydrotestosterone benzoate; DHT benzoate; DHTB; 5α-Androstan-17β-ol-3-one 17β-benzoate |
Routes of administration | Intramuscular injection |
Drug class | Androgen; Anabolic steroid; Androgen ester |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.012.629 |
Chemical and physical data | |
Formula | C26H34O3 |
Molar mass | 394.555 g·mol−1 |
3D model (JSmol) | |
| |
|
Androstanolone benzoate (brand names Ermalone-Amp, Hermalone, Sarcosan), also known as stanolone benzoate or dihydrotestosterone benzoate (DHTB), as well as 5α-androstan-17β-ol-3-one 17β-benzoate, is a synthetic androgen and anabolic steroid and a dihydrotestosterone ester.[1][2] It is used as an injectable and acts as a prodrug of androstanolone (stanolone, dihydrotestosterone, DHT).
See also
[edit]References
[edit]- ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 640–. ISBN 978-1-4757-2085-3.
- ^ Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 261–. ISBN 978-94-011-4439-1.